Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE PMR
NL-OMON59356Phase 4Active, not recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Feb 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of rituximab, sponsored by Sint Maartenskliniek. Started Feb 2023; status: active, not recruiting.
02
Drugs
rituximab
Beyond the preview
Go deeper on NL-OMON59356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59356.